FDA Drug recall D-423-2013
Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles (NDC 607…
- FDA Drug
- Class II
- terminated
- Published 2013-05-29
On 2013-05-29 the FDA classified a Class II recall of Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles (NDC 607… by King Legacy A Wholly Owned Subsidiary, citing subpotent Drug: The products were below specification for potency at the expiry stability point.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-423-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-04-30 |
| Published | 2013-05-29 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | King Legacy A Wholly Owned Subsidiary |
| Distribution | US |
Product
Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles (NDC 60793-852-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
Reason
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Identifiers
| ndc | 60793-850-10 |
|---|---|
| ndc | 60793-850-01 |
| ndc | 60793-851-10 |
| ndc | 60793-851-01 |
| ndc | 60793-852-10 |
| ndc | 60793-852-01 |
| ndc | 60793-853-10 |
| ndc | 60793-853-01 |
| ndc | 60793-854-10 |
| ndc | 60793-854-01 |
| ndc | 60793-855-10 |
| ndc | 60793-855-01 |
| ndc | 60793-856-10 |
| ndc | 60793-856-01 |
| ndc | 60793-857-10 |
| ndc | 60793-857-01 |
| ndc | 60793-858-10 |
| ndc | 60793-858-01 |
| ndc | 60793-859-10 |
| ndc | 60793-859-01 |
| ndc | 60793-860-10 |
| ndc | 60793-860-01 |
| code_info | Lot # a) 64197, Exp. 4/13; 64339, Exp. 4/13; 65061, Exp. 5/13; 65236, Exp. 6/13; 65917, Exp. 8/13; 66122, Exp. 8/13; an…Lot # a) 64197, Exp. 4/13; 64339, Exp. 4/13; 65061, Exp. 5/13; 65236, Exp. 6/13; 65917, Exp. 8/13; 66122, Exp. 8/13; and 66427, Exp. 9/13; b) 64340, Exp. 4/13; 64933, Exp. 4/13; 65062, Exp. 5/13; 65237, Exp. 6/13; 65238, Exp. 6/13; and 66121, Exp. 8/13 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-423-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.